TGFB1 and neoplasm: In the initial phases of carcinogenesis, the TGF-β signaling pathway suppresses tumor growth, while inactivity or alterations in this pathway may occur due to mutations or the deletion of its components, resulting in tumor promotion, as observed in significant fractions of colon, pancreatic, and gastric malignancies [33,34,35,36,37,38].